Berry R W, Abraha A, Lagalwar S, LaPointe N, Gamblin T C, Cryns V L, Binder L I
Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, Illinois 60611, USA.
Biochemistry. 2003 Jul 15;42(27):8325-31. doi: 10.1021/bi027348m.
Abnormal aggregation of the microtubule-associated protein, tau, occurs in many neurodegenerative diseases, making it important to understand the mechanisms of tau polymerization. Previous work has indicated that the C-terminal region of tau inhibits polymerization in vitro, and a growing body of evidence implicates caspase cleavage of tau at Asp 421 in the C-terminus as an important inducer of tau polymerization in Alzheimer's disease. In the present study, we provide evidence that the C-terminal peptide fragment produced by caspase cleavage inhibits tau polymerization, suggesting that caspase cleavage of tau enhances its polymerization by removing the inhibitory control element. Moreover, we provide evidence that the peptide assumes an alpha-helical configuration and inhibits tau assembly by interacting with residues 321-375 in the microtubule binding repeat region. These findings indicate that formation of the fibrillar pathologies during the course of Alzheimer's disease may be driven or sustained by apoptotic events leading to caspase activation.
微管相关蛋白tau的异常聚集发生在许多神经退行性疾病中,因此了解tau蛋白聚合的机制非常重要。先前的研究表明,tau蛋白的C末端区域在体外可抑制聚合,越来越多的证据表明,在阿尔茨海默病中,tau蛋白在C末端的天冬氨酸421处被半胱天冬酶切割是tau蛋白聚合的重要诱导因素。在本研究中,我们提供的证据表明,半胱天冬酶切割产生的C末端肽片段可抑制tau蛋白聚合,这表明tau蛋白的半胱天冬酶切割通过去除抑制控制元件而增强其聚合。此外,我们提供的证据表明,该肽呈现α螺旋结构,并通过与微管结合重复区域中的321-375位残基相互作用来抑制tau蛋白组装。这些发现表明,阿尔茨海默病病程中纤维状病变的形成可能由导致半胱天冬酶激活的凋亡事件驱动或维持。